NAVITAS-WIND
2.2.2024 16:36:28 CET | Business Wire | Press release
As of February 1, 2024, Executive Partner Maciej Suchy and Executive Partner Adam Bartelik have joined the ownership circle of Navitas Wind A/S. The new co-owners bring solid knowledge and experience from the Renewable energy sector, thereby increasing Navitas Wind’s momentum in the International market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240202857457/en/
The new ownership group and board of directors of Navitas Wind A/S. From left Maciej Suchy, Rene Kildsgaard, Martin Jacobsen, Kuno jacobsen, Glenn Aagesen and Adam Bartelik. (Photo: Business Wire)
Kuno Jacobsen, CEO of Navitas Wind A/S:
“Since our Start in 2019, we have devoted many internal resources to creating a robust foundation for Navitas Wind. Within the management team, we have focused on developing an organization with a strong, industrious drive and a professional mindset – for both customers and employees. Now we enter Navitas’ fifth year of existence and continue our growth journey together with Maciej and Adam. This will enable us, among other things, to develop the company’s competencies, expand our business area, and focus even more on international projects.”
Internationally Experienced Individuals from the Industry:
Short about Maciej Suchy
Extensive operational and commercial experience within the Wind Energy Sector, specialising in construction project management, sales, and business development and people management.
Maciej says: “I feel extremely lucky, thrilled and excited to join this enthusiastic organisation, where the Quality Service is achieved through an innovative Fun&Work approach. Where the PROUD and HAPPY team can only focus on delivering their BEST to the Customers’ satis- faction. How cool is that..? With humble respect, I am committed to doing my best in growing further the Navitas Company with all new innovative projects.”
Short about Adam Bartelik
Extensive operational and project engineering experience within the Wind Energy Sector, specialising in construction project management, new concepts development and people management.
Adam says: ”Passion, and challenges, not an easy business, can only be done with people with the same vision. Creating, developing and constantly improving the company so that everyone is proud to be part of it. This is what motivates me to work with Navitas with friends on a private and professional level. I can’t wait to help develop a company that meets the customer’s needs and is an ideal place to work for our employees. Let’s move to the next level.”
Navitas’s strategic decision to onboard Maciej and Adam is an important milestone in fortifying our corporate capabilities. It is essential for moving the company into its next phase of development. Our objective is to broaden our geographical reach and broaden the range of solutions we offer to our clients, positioning Navitas as an all-in-one hub, turn-key supplier, in the Renewable Energy sector.
Both Maciej and Adam bring a dynamic blend of drive and expertise, pivotal in supporting our ambitious journey. Their involvement in the strategic planning process, ensuring Navitas’s sustained growth and solidifying our position in the market.
The energy sector is facing a crucial industrialization phase internationally.
At Navitas, we believe that our efforts to integrate advanced technology and sustainable methods will be key to achieving a more sustainable future. By securing the future growth of Navitas Wind A/S and maintaining our high-quality level in the wind industry, we confidently move into a new and exciting phase of the company growth.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240202857457/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom